Annual Drug Patent Expirations for PROMACTA Promacta is a drug marketed by Novartis and is included in two NDAs. It is available from one supplier. There are eight patents protecting…
The post New patent expiration for Novartis drug PROMACTA appeared f…
New patent expiration for Novartis drug PROMACTA Read Post »
NUCYNTA ER (tapentadol hydrochloride) Collegium pharm inc Patent: 8,309,060 Expiration: Nov 20, 2023 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs,…
The post Drug Patent Expirations…
Drug Patent Expirations for the Week of November 19, 2023 Read Post »
Annual Drug Patent Expirations for PROMACTA+KIT Promacta Kit is a drug marketed by Novartis and is included in one NDA. It is available from one supplier. There are three patents…
The post New patent expiration for Novartis drug PROMACTA KIT appeared f…
New patent expiration for Novartis drug PROMACTA KIT Read Post »
Annual Drug Patent Expirations for NUCYNTA+ER Nucynta Er is a drug marketed by Collegium Pharm Inc and is included in one NDA. It is available from one supplier. There are…
The post New patent expiration for Collegium Pharm drug NUCYNTA ER appeared fir…
New patent expiration for Collegium Pharm drug NUCYNTA ER Read Post »
Annual Drug Patent Expirations for OXYCONTIN Oxycontin is a drug marketed by Purdue Pharma Lp and is included in one NDA. It is available from five suppliers. There are twenty-one…
The post New patent expiration for Purdue Pharma drug OXYCONTIN appeare…
New patent expiration for Purdue Pharma drug OXYCONTIN Read Post »
Annual Drug Patent Expirations for HYSINGLA+ER Hysingla Er is a drug marketed by Purdue Pharma Lp and is included in one NDA. It is available from one supplier. There are…
The post New patent expiration for Purdue Pharma drug HYSINGLA ER appeared first…
New patent expiration for Purdue Pharma drug HYSINGLA ER Read Post »
Annual Drug Patent Expirations for OPANA+ER Opana Er is a drug marketed by Endo Pharms and is included in two NDAs. There are eleven patents protecting this drug and six…
The post New patent expiration for Endo Pharms drug OPANA ER appeared first on Dr…
New patent expiration for Endo Pharms drug OPANA ER Read Post »
Annual Drug Patent Expirations for FOTIVDA Fotivda is a drug marketed by Aveo Pharms and is included in one NDA. It is available from one supplier. There are three patents…
The post New patent expiration for Aveo Pharms drug FOTIVDA appeared first on D…
New patent expiration for Aveo Pharms drug FOTIVDA Read Post »
Annual Drug Patent Expirations for EXFORGE+HCT Exforge Hct is a drug marketed by Novartis and is included in one NDA. It is available from one supplier. There are two patents…
The post New patent expiration for Novartis drug EXFORGE HCT appeared first …
New patent expiration for Novartis drug EXFORGE HCT Read Post »
Annual Drug Patent Expirations for POMALYST Pomalyst is a drug marketed by Bristol and is included in one NDA. It is available from one supplier. There are six patents protecting…
The post New patent expiration for Bristol drug POMALYST appeared first …